Navigation Links
Endologix to Present at Two Upcoming Conferences
Date:8/3/2011

IRVINE, Calif., Aug. 3, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at two upcoming investor conferences.  The first presentation will be at the 31st Annual Canaccord Genuity Growth Conference in Boston, MA.   Event:31st Annual Canaccord Genuity Growth Conference   Date:Thursday, August 11, 2011   Time:10:00 a.m. ETThe second presentation will be at Wedbush Securities 2011 Life Sciences Management Access Conference in New York.

  Event:Wedbush Securities 2011 Life Sciences Management Access Conference   Date:Tuesday, August 16, 2011   Time:1:50 p.m. ETAn audio Web cast of the Company's presentations will be available by visiting the investor relations section of Endologix's Web site at www.endologix.com.  A replay of the presentations will be available for 30 days.

About Endologix, Inc.Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S.  The Nellix® Endovascular System and Ventana™ Fenestrated Stent Graft System are investigational devices.  Additional information can be found on Endologix's Web site at www.endologix.com. COMPANY CONTACT:

INVESTOR
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Endologix Reports 22% Second Quarter 2011 Revenue Growth
2. Endologix and LeMaitre Vascular Enter Early Termination Agreement for European Distribution Rights of Endologix Products
3. Endologix to Report Second Quarter 2011 Financial Results on July 21, 2011
4. Endologix Announces FDA Approval of AFX™ Endovascular AAA System
5. Endologix to Present at the 2011 Bank of America Merrill Lynch Health Care Conference
6. Endologix Files Form 10-K; Nellix Purchase Price Allocation Finalized
7. Endologix to Present at the ROTH 23rd Annual OC Growth Stock Conference
8. Endologix Reports 41% Fourth Quarter 2010 Revenue Growth
9. Endologix Announces Presentation of Favorable Initial PEVAR Trial Results
10. Endologix Announces Favorable Clinical Results for Nellix Technology
11. Endologix to Report Fourth Quarter and Full Year 2010 Financial Results on February 22, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/12/2013)... Dec. 12, 2013  Rafarma Pharmaceuticals (OTC:RAFA), announces a ... $1.2 million private placement has been closed with a ... private placement are being applied to company expansion and ... Dave Anderson : "As Rafarma continues to develop ... is just the beginning of a vibrant private financing ...
(Date:12/12/2013)... , Dec. 12, 2013  The Child Mind Institute ... fourth annual Child Advocacy Award Dinner at Cipriani 42 ... Child Mind Institute to continue providing life-changing mental health ... education and outreach efforts. The event, ... Sundaram , partner at Goldman Sachs and Child Mind ...
(Date:12/12/2013)... , Dec. 12, 2013 BMC Medical Co., Ltd ... and headquartered in China . On ... trade show in Düsseldorf, Germany , ... the District Court Munich I, Germany ... in Germany including BMC,s RESmart ...
Breaking Medicine Technology:Rafarma Pharmaceuticals Announces a $1.2 Million Private Placement 2Child Mind Institute Raises $6.6 Million at Annual Child Advocacy Award Dinner for the Advancement of Children's Mental Health and Brain Research 2Child Mind Institute Raises $6.6 Million at Annual Child Advocacy Award Dinner for the Advancement of Children's Mental Health and Brain Research 3BMC to protect its rights in patent fight with ResMed 2
(Date:12/12/2013)... 12, 2013 Neda Azadivatan is calling ... Untreated gum disease is a chronic infection in the ... this type of infection. Gum disease, in turn, can ... lead to elevated blood glucose levels. Dr. Azadivatan recommends ... possible to decrease their risk of developing diabetes and ...
(Date:12/12/2013)... iFitDress.com, a popular online shop of wedding dresses ... discounts, from 20% to 70% off, on all its ... (Style D46096), Hot Pink Glamorous Full Skirt Sleeveless Criss-cross ... at $325, and it is provided at a new ... discount prom gowns , the company is also ...
(Date:12/12/2013)... New York, New York (PRWEB) December 12, 2013 ... many that allege use of the antipsychotic drug caused ... male breast growth, continue to move forward in a ... Pleas in Pennsylvania. According to a brief filed earlier ... a request from Johnson & Johnson to allow some ...
(Date:12/12/2013)... mHealthSummit 2013 – Washington ... and Aventyn Inc. announced a collaboration ... remote monitoring platform and Vital Connect HealthPatch MD biosensor ... to help clinicians better manage chronic disease patient populations, ... readmissions. , Vital Connect is an industry pioneer of ...
(Date:12/12/2013)... 13, 2013 Recently, 4leafcity.com has announced its ... at its online shop. Included in the new range are ... been considered as one of the best clothing suppliers in ... 4leafcity.com provides high quality products and great customer service. , ... on all these new designs; they are available at low ...
Breaking Medicine News(10 mins):Health News:Dr. Neda Azadivatan Focuses on Raising Awareness of the Link Between Diabetes and Gum Disease this December 2Health News:Discount Prom Gowns From a Well-Known Company, iFitDress.com 2Health News:Risperdal Lawsuits Progress, as Bernstein Liebhard LLP Notes Filing of Plaintiff Brief Seeking to Unseal Risperdal Clinical Studies 2Health News:Risperdal Lawsuits Progress, as Bernstein Liebhard LLP Notes Filing of Plaintiff Brief Seeking to Unseal Risperdal Clinical Studies 3Health News:Vital Connect, Aventyn Launch Wearable Biosensor Platform for Mobile Patient Monitoring 2Health News:Vital Connect, Aventyn Launch Wearable Biosensor Platform for Mobile Patient Monitoring 3Health News:Vital Connect, Aventyn Launch Wearable Biosensor Platform for Mobile Patient Monitoring 4Health News:4leafcity.com Announces Its Cheap Men’s Jackets and Coats to Benefit Worldwide Customers 2
... Extremely obese children have a 40 percent higher risk ... moderately obese have a 30 percent higher risk of ... Kaiser Permanente study published online in the International ... study establishes an association between obesity and GERD in ...
... Angeles, CA (July 8, 2010) The American Journal ... endorsed by Men,s Health Network. Men,s Health Network ... to reach men and their families where they live, ... tools, screening programs, educational materials, advocacy opportunities, and patient ...
... Long Awaited Classical ... Florida based Feng Shui Undergraduate/Graduate program is offering its first leg of program curriculum, i.e. ... ... organization Earthluck International through its CEO Angel de Para, is following through with its commitment ...
... HealthDay Reporter , THURSDAY, July 8 (HealthDay News) -- Scientists ... HIV: antibody "soldiers" in the immune system that might prevent ... to the researchers, these newly found antibodies connect with and ... strains, involving all major genetic subtypes of the virus. ...
... small molecule decoy, investigators funded by the Samuel ... protein interactions and induce epigenetic reprogramming in human ... gene expression of breast cancer cells to behave ... what may perhaps become an effective targeted epigenetic ...
... Tropical disease specialist Joseph Vinetz, MD, of the University ... an ambitious multi-national effort to help control and eventually ... Excellence in Malaria Research Center (ICEMR) with a seven-year, ... The grant is one of 10 awards ...
Cached Medicine News:Health News:Extremely obese children have 40 percent higher risk of reflux disease of esophagus 2Health News:Extremely obese children have 40 percent higher risk of reflux disease of esophagus 3Health News:Feng Shui Expert Practitioner and Analyst Angel de Para Announces Classical Feng Shui Practitioner Workshop in New York City. 2Health News:New Anti-HIV Weapons Found in Immune System 2Health News:Scientists reprogram triple-negative breast cancer cells to respond to tamoxifen 2Health News:UC San Diego to lead new malaria research center in South America 2Health News:UC San Diego to lead new malaria research center in South America 3Health News:UC San Diego to lead new malaria research center in South America 4
... Array systems are fully automated ... fast turnaround of highly accurate ... drug monitoring (TDM) results. Using ... the easy-to-use Array® 360 performs ...
ELISA kit for detection of Rheumatoid Factor....
... create tired, dry eyes. With ACUVUE OASYS IN, ... challenging environments can make your eyes feel tired ... a computer can leave your eyes craving moisture. ... PLUS Brand Contact Lenses. It will almost ...
... Better. Introducing Disposable Bimanuals. With the ... need for quality single-use bimanuals. Oasis meets ... NEW disposable bimanuals. Single use bimanuals decrease ... time, they encompass all the advantages of ...
Medicine Products: